Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection
Edaravone, the first known free radical scavenger, has demonstrated cellular protective properties in animals and humans. Owing to its antioxidant activity, edaravone modulates oxidative damage in various diseases, especially neurodegenerative diseases. In 2015, edaravone was approved in Japan to tr...
Những tác giả chính: | Sun Joo Cha, Kiyoung Kim |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
MDPI AG
2022-01-01
|
Loạt: | Antioxidants |
Những chủ đề: | |
Truy cập trực tuyến: | https://www.mdpi.com/2076-3921/11/2/195 |
Những quyển sách tương tự
-
A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone
Bằng: Erdi Şahin
Được phát hành: (2018-03-01) -
Edaravone: A new hope for patients with amyotrophic lateral sclerosis
Bằng: Shivangi Garg, et al.
Được phát hành: (2019-01-01) -
Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan
Bằng: Hideki Houzen, et al.
Được phát hành: (2021-07-01) -
Long-term outcomes of edaravone in amyotrophic lateral sclerosis in South Korea: 72-week observational study
Bằng: Jin-Mo Park, et al.
Được phát hành: (2022-07-01) -
Cost-utility analysis for sublingual versus intravenous edaravone in the treatment of amyotrophic lateral sclerosis
Bằng: Chang Liu, et al.
Được phát hành: (2024-10-01)